BACKGROUND: Neuropeptide Y (NPY) is an important central orexigenic hormone predominantly produced by the hypothalamus, and recently found to be secreted in adipose tissue (AT). Acipimox (Aci) inhibits lipolysis in AT and reduces plasma glycerol and free fatty acid (FFA) levels. Exercise and Aci are enhancers of growth hormone (GH) and NPY secretion and exercise may alter leptin levels. We expect to find abnormal neuropeptidergic response in plasma and AT in patients with bulimia nervosa (BN). We hypothesize that Aci influences these peptides via a FFA-independent mechanism and that Aci inhibits lipolysis through a cyclic adenosine monophosphate (cAMP)-dependent pathway. Dysregulations of the AT-brain axis peptides might be involved in binge eating as is the case in BN. METHODS: The objective of this study was to determine the responses of plasma NPY, GH, leptin, FFA and glycerol levels to exercise in BN patients and healthy women (C) given the anti-lipolytic drug Aci or placebo. The secondary objective of this study was to compare the responses of extracellular glycerol levels and plasma glycerol levels to exercise alone or together with Aci administration in BN patients and C women. Extracellular glycerol was measured in vivo in subcutaneous (sc) abdominal AT using microdialysis. Eight BN and eight C women were recruited for this single-blind, randomized study. Aci or placebo was given 1 hour before the exercise (45 min, 2 W/kg of lean body mass [LBM]). NPY, GH, leptin, FFA, glycerol plasma and AT glycerol levels were measured using commercial kits. RESULTS: The primary outcome of this study was that the exercise with Aci administration resulted in plasma NPY and GH increase (after a 45-minute exercise) and leptin (after a 90-minute post-exercise recovering phase) increased more in BN patients. The secondary outcomes of this study were that the exercise with Aci administration induced a higher decrease of extracellular glycerol in BN patients compared to the C group, while the exercise induced a higher increase of glycerol concentrations in sc abdominal AT of BN patients. Plasma glycerol levels decreased more in BN patients and plasma FFA levels were depressed in both groups after the exercise with Aci administration. The exercise induced similar increases in plasma NPY, GH, FFA and glycerol levels, and a similar decrease in the plasma leptin level in both groups. CONCLUSIONS: We confirm the results of a single-blind, randomized, microdialysis study, i.e. that the Aci-induced elevation in plasma NPY and GH levels during the exercise is higher in BN patients and that Aci increased plasma leptin levels in the post-exercise recovering phase (90-minute) more in BN patients. The post-exercise rise (45-minute) in AT glycerol is much more attenuated by acute Aci treatment in BN patients. Simultaneously, we found facilitated turnover of plasma glycerol after the exercise together with Aci administration in BN. Our results support the hypotheses that Aci exerts an effect on the FFA-independent and cAMP-dependent mechanism. TRIAL REGISTRATION: Australia and New Zealand Clinical Trials Register (ANZCTR): ACTRN12611000955910.

Institute of Endocrinology Laboratory of Clinical and Experimental Neuroendocrinology Narodni 8 116 94 Prague 1 Czech Republic

Psychiatric Clinic 1st Faculty of Medicine Charles University Ke Karlovu 11 121 08 Prague 2 Czech Republic

Zobrazit více v PubMed

Torsello A, Brambilla F, Tamiazzo L, Bulgarelli I, Rapetti D. Central dysregulations in the control of energy homeostasis and endocrine alterations in anorexia and bulimia nervosa. J Endocrinol Invest. 2007;30:962–976. PubMed

Turtzo LC, Lane MD. NPY and neuron-adipocyte interactions in the regulation of metabolism. EXS. 2006;95:133–141. PubMed

Kos K, Baker AR, Jernas M, Harte AL, Clapham JC, O'Hare JP, Carlsson L, Kumar S, McTernan PG. DPP-IV inhibition enhances the antilipolytic action of NPY in human adipose tissue. Diabetes Obes Metab. 2009;11:285–292. doi: 10.1111/j.1463-1326.2008.00909.x. PubMed DOI

Kos K, Harte AL, James S, Snead DR, O'Hare JP, McTernan PG, Kumar S. Secretion of neuropeptide Y in human adipose tisssue and its role in maintance of adipose tissue mass. Am J Physiol Endocrinol Metab. 2007;293:E1335–1340. doi: 10.1152/ajpendo.00333.2007. PubMed DOI

Vendelbo MH, Jørgensen JO, Pedersen SB, Gormsen LC, Lund S, Schmitz O, Jessen N, Møller N. Exercise and fasting activate growth hormone-dependent myocellular signal transducer and activator of transcription-5b phosphorylation and insulin-like growth factor-I messenger ribonucleic acid expression in humans. J Clin Endocrinol Metab. 2010;95:E64–E68. doi: 10.1210/jc.2010-0689. PubMed DOI

Rask-Andersen M, Olszewski PK, Levine AS, Schiöth HB. Molecular mechanisms underlying anorexia nervosa: Focus on human gene association studies and systems controlling food intake. Brain Res Rev. 2010;62:147–164. doi: 10.1016/j.brainresrev.2009.10.007. PubMed DOI

Eaton K, Sallee FR, Sah R. Relevance of neuropeptide Y (NPY) in psychiatry. Curr Top Med Chem. 2007;7:1645–1659. doi: 10.2174/156802607782341037. PubMed DOI

Gruninger TR, LeBoeuf B, Liu Y, Garcia LR. Molecular signaling involved in regulating feeding and other motivated behaviors. Mol Neurobiol. 2007;35:1–20. doi: 10.1007/BF02700621. PubMed DOI

Karamouzis I, Karamouzis M, Vrabas IS, Christoulas K, Kyriazis N, Giannoulis E, Mandroukas K. The effects of marathon swimming on serum leptin and plasma neuropeptide Y levels. Clin Chem Lab Med. 2002;40:132–136. doi: 10.1515/CCLM.2002.023. PubMed DOI

Kok P, Buijs MM, Kok SW. Acipimox enhances spontaneous growth hormone secretion in obese women. Am J Physiol Regul Integr Comp Physiol. 2004;286:R693–698. doi: 10.1152/ajpregu.00595.2003. PubMed DOI

de Vries WR, Schers TJ, Ait Abdesselam S, Osman-Dualeh M, Maitimu I, Koppeschaar HP. Involvement of endogenous growth hormone-releasing hormone (GHRH) in the exercise-related response of growth hormone. Int J Sports Med. 2003;24:208–211. doi: 10.1055/s-2003-39093. PubMed DOI

Taylor JC, Yang HT, Laughlin MH, Terjung RL. α-Adrenergic and neuropeptide Y Y1 receptor control of collateral circuit conductance: influence of exercise training. J Physiol. 2008;586:5983–5998. doi: 10.1113/jphysiol.2008.160101. PubMed DOI PMC

Teske JA, Billington CJ, Kotz CM. Neuropeptidergic mediators of spontaneous physical activity and non-exercise activity thermogenesis. Neuroendocrinology. 2008;87:71–90. doi: 10.1159/000110802. PubMed DOI

Jürimäe J, Mäestu J, Jürimäe T, Mangus B, von Duvillard SP. Peripheral signals of energy homeostasis as possible markers of training stress in athletes: a review. Metabolism. 2011;60:335–350. doi: 10.1016/j.metabol.2010.02.009. PubMed DOI

Coiro V, Casti A, Volta E, Melani A, Rubino P, Saccani-Jotti G, Volpi R, Chiodera P. Effect of physical traininig on reduction of circulating neuropeptide Y levels in elderly humans. J Endocrinol Invest. 2010;33:132–133. PubMed

Nedvidkova J, Smitka K, Papezova H, Vondra K, Hill M, Hainer V. Acipimox during exercise points to an inhibitory feedback of GH on ghrelin secretion in bulimic and healthy women. Regul Pept. 2011;167:134–139. doi: 10.1016/j.regpep.2010.12.012. PubMed DOI

Gendall KA, Kaye WH, Altemus M, McConaha CW, La Via MC. Leptin, neuropeptide Y, and peptide YY in long-term recovered eating disorder patients. Biol Psychiatry. 1999;46:292–299. doi: 10.1016/S0006-3223(98)00292-3. PubMed DOI

Nedvidkova J, Papezova H, Haluzik M, Schreiber V. Interaction between serum leptin levels and hypothalamo-hypophyseal-thyroid axis in patients with anorexia nervosa. Endocr Res. 2000;26:219–230. doi: 10.3109/07435800009066163. PubMed DOI

Scherag S, Hebebrand J, Hinney A. Eating disorders: the current status of molecular genetic research. Eur Child Adolesc Psychiatry. 2010;19:211–226. PubMed PMC

Scacchi M, Pincelli AI, Cavagnini F. Nutritional status in the neuroendocrine control of growth hormone secretion: the model of anorexia nervosa. Front Neuroendocrinol. 2003;24:200–224. doi: 10.1016/S0091-3022(03)00014-1. PubMed DOI

Fazeli PK, Lawson EA, Prabhakaran R, Miller KK, Donoho DA, Clemmons DR, Herzog DB, Misra M, Klibanski A. Effects of recombinant human growth hormone in anorexia nervosa: A randomized, placebo-controlled study. J Clin Endocrinol Metab. 2010;95:4889–4897. doi: 10.1210/jc.2010-0493. PubMed DOI PMC

Bartak V, Vybiral S, Papezova H, Dostalova I, Pacak K, Nedvidkova J. Basal and exercise induced sympathetic nervous activity and lipolysis in adipose tissue of patients with anorexia nervosa. Eur J Clin Invest. 2004;34:371–377. doi: 10.1111/j.1365-2362.2004.01344.x. PubMed DOI

Duclos M, Corcuff JB, Ruffie A, Roger P, Manier G. Rapid leptin decrease in immediate post-exercise recovery. Clin Endocrinol. 1999;50:337–342. doi: 10.1046/j.1365-2265.1999.00653.x. PubMed DOI

Stumvoll M, Fritsche A, Tschritter O, Lehmann R, Wahl HG, Renn W, Häring H. Leptin levels in humans are acutely suppressed by isoproterenol despite acipimox-induced inhibition of lipolysis, but not by free fatty acids. Metabolism. 2000;49:335–339. doi: 10.1016/S0026-0495(00)90198-7. PubMed DOI

Wang-Fisher YL, Han J, Guo W. Acipimox stimulates leptin production from isolated rat adipocytes. J Endocrinol. 2002;174:267–272. doi: 10.1677/joe.0.1740267. PubMed DOI

Meguid MM, Yang ZJ, Gleason JR. The gut-brain brain-gut axis in anorexia: toward an understanding of food intake regulation. Nutrition. 1996;12:S57–S62. PubMed

Romijn JA, Corssmit EP, Havekes LM, Pijl H. Gut-brain axis. Curr Opin Clin Nutr Metab Care. 2008;11:518–521. doi: 10.1097/MCO.0b013e328302c9b0. PubMed DOI

Sedlackova D, Kopeckova J, Papezova H, Vybíral S, Kvasnickova H, Hill M, Nedvidkova J. Changes of plasma obestatin, ghrelin and NPY in anorexia and bulimia nervosa before and after a high carbohydrate breakfast. Physiol Res. 2011;60:165–173. PubMed

Coiro V, Volpi R, Marchesi C, Capretti L, Speroni G, Rossi G, Caffari G, De Ferri. Abnormal growth hormone and cortisol, but not thyroid-stimulating hormone, responses to an intravenous glucose tolerance test in normal-weight, bulimic women. Psychoneuroendocrinology. 1992;17:639–645. doi: 10.1016/0306-4530(92)90022-Y. PubMed DOI

Langin D. Control of fatty acid and glycerol release in adipose tissue lipolysis. C R Biologies. 2006;329:598–607. doi: 10.1016/j.crvi.2005.10.008. PubMed DOI

Soudijn W, Wijngaarden I, Ijzerman AP. Nicotinic acid receptor subtypes and their ligands. Med Res Rev. 2007;27:417–433. doi: 10.1002/med.20102. PubMed DOI

Karpe F, Frayn KN. The nicotinic acid receptor - a new mechanism for an old drug. Lancet. 2004;363:1892–1894. doi: 10.1016/S0140-6736(04)16359-9. PubMed DOI

American Psychiatric Association 1994. Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) 4. Washington, DC: American Psychiatric Press; 1994.

Dostalova I, Pacak K, Nedvidkova J. Application of in vivo microdialysis to measure leptin concentration in adipose tissue. Int J Biol Macromol. 2003;32:205–208. doi: 10.1016/S0141-8130(03)00055-2. PubMed DOI

Nogueiras R, Williams LM, Dieguez C. Ghrelin: new molecular pathways modulating appetite and adiposity. Obes Facts. 2010;3:285–292. PubMed PMC

Coiro V, Saccani-Jotti G, Rubino P, Manfredi G, Melani A, Chiodera P. Effects of ghrelin on circulating neuropeptide Y levels in humans. Neuro Endocrinol Lett. 2006;27:755–757. PubMed

Briggs DI, Andrews ZB. Metabolic status regulates ghrelin secretion on energy homeostasis. Neuroendocrinology. 2011;93:48–57. doi: 10.1159/000322589. PubMed DOI

Chan YY, Steiner RA, Clifton DK. Regulation of hypothalamic neuropeptide Y neurons by growth hormone in the rat. Endocrinology. 1996;137:1319–1325. doi: 10.1210/en.137.4.1319. PubMed DOI

Shintani M, Ogawa Y, Ebihara K, Aizawa-Abe M, Miyanaga F, Takaya K, Hayashi T, Inoue G, Hosoda K, Kojima M, Kangawa K, Nakao K. Ghrelin, an endogenous growth hormone secretagogue, is a novel orexigenic peptide that antagonizes leptin action through activation of hypothalamic neuropeptide Y/Y1 receptor pathway. Diabetes. 2001;50:227–232. doi: 10.2337/diabetes.50.2.227. PubMed DOI

Deltondo J, Por I, Hu W, Merchenthaler I, Semeniken K, Jojart J, Dudas B. Associations between the human growth hormone-releasing hormone- and neuropeptide-Y-immunoreactive systems in the human diencephalon: a possible morphological substrate of the impact of stress on growth. Neuroscience. 2008;153:1146–1152. doi: 10.1016/j.neuroscience.2008.02.072. PubMed DOI

Kamegai J, Minami S, Sugihara H, Hasegawa O, Higuchi H, Wakabayashi I. Growth hormone receptor gene is expressed in neuropeptide Y neurons in hypothalamic arcuate nucleus of rats. Endocrinology. 1996;137:2109–2112. doi: 10.1210/en.137.5.2109. PubMed DOI

Chen JX, Zhao X, Yue GX, Wang ZF. Influence of acute and chronic treadmill exercise on rat plasma lactate and brain NPY, L-ENK, DYN A1-13. Cell Mol Neurobiol. 2007;27:1–10. doi: 10.1007/s10571-006-9110-4. PubMed DOI PMC

Coiro V, Volpi R, Cataldo S, Araldi A, Stella A, Saccani-Jotti G, Maffei ML, Volta E, Chiodera P. Somatostatin reduces neuropeptide Y rise induced by physical exercise. Horm Metab Res. 2011;43:361–363. doi: 10.1055/s-0031-1273681. PubMed DOI

Dostalova I, Bartak V, Papezova H, Nedvidkova J. The effect of short-term exercise on plasma leptin levels in patients with anorexia nervosa. Metabolism. 2007;56:497–503. doi: 10.1016/j.metabol.2006.11.008. PubMed DOI

Bartak V, Nedvidkova J, Vybiral S, Dostalova I, Papezova H, Simon M, Drbalova K, Vondra K, Pacak K. Adrenergic regulation of lipolysis in patients with anorexia nervosa during exercise. Physiol Res. 2003;52:24.

Nedvidkova J, Dostalova I, Bartak V, Papezova H, Pacak K. Increased subcutaneous abdominal tissue norepinephrine levels in patients with anorexia nervosa: an in vivo microdialysis study. Physiol Res. 2004;53:409–413. PubMed

Gomez-Merino D, Chennaoui M, Drogou C, Bonneau D, Guezennec CY. Decrease in serum leptin after prolonged physical activity in men. Med Sci Sports Exerc. 2002;34:1594–1599. doi: 10.1097/00005768-200210000-00010. PubMed DOI

Dostalova I, Smitka K, Papezova H, Kvasnickova H, Nedvidkova J. Increased insulin sensitivity in patients with anorexia nervosa: the role of adipocytokines. Physiol Res. 2007;56:587–594. PubMed

Vestergaard ET, Hansen TK, Nielsen S, Moller N, Christiansen JS, Jorgensen JOL. Effects of GH replacement therapy in adults on serum levels of leptin and ghrelin: the role of lipolysis. Eur J Endocrinol. 2005;153:545–549. doi: 10.1530/eje.1.02000. PubMed DOI

Worm D, Vinten J, Vaag A, Henriksen JE, Beck-Nielsen H. The nicotinic acid analogue acipimox increases plasma leptin and decreases free fatty acids in type 2 diabetic patients. Eur J Endocrinol. 2000;143:389–395. doi: 10.1530/eje.0.1430389. PubMed DOI

Allick G, Sprangers F, Weverling GJ, Ackermans MT, Meijer AJ, Romijn JA, Endert E, Bisschop PH, Sauerwein HP. Free fatty acids increase hepatic glycogen content in obese males. Metabolism. 2004;53:886–893. doi: 10.1016/j.metabol.2004.01.012. PubMed DOI

Lissett CA, Clayton PE, Shalet SM. The acute leptin response to GH. J Clin Endocrinol Metab. 2001;86:4412–4415. doi: 10.1210/jc.86.9.4412. PubMed DOI

Dostalova I, Kopsky V, Duskova J, Papezova H, Pacak K, Nedvidkova J. Leptin concentrations in the abdominal subcutaneous adipose tissue of patients with anorexia nervosa assessed by in vivo microdialysis. Regul Pept. 2005;128:63–68. doi: 10.1016/j.regpep.2004.12.029. PubMed DOI

Lafontan M, Langin D. Lipolysis and lipid mobilization in human adipose tissue. Prog Lipid Res. 2009;48:275–297. doi: 10.1016/j.plipres.2009.05.001. PubMed DOI

Coiro V, Casti A, Rubino P, Manfredi G, Maffei ML, Melani A, Saccani Jotti G, Chiodera P. Free fatty acids inhibit adrenocorticotropin and cortisol secretion stimulated by physical exercise in normal men. Clin Endocrinol. 2007;66:740–743. doi: 10.1111/j.1365-2265.2007.02792.x. PubMed DOI

Current Aspects of the Role of Autoantibodies Directed Against Appetite-Regulating Hormones and the Gut Microbiome in Eating Disorders

Acipimox Administration With Exercise Induces a Co-feedback Action of the GH, PP, and PYY on Ghrelin Associated With a Reduction of Peripheral Lipolysis in Bulimic and Healthy-Weight Czech Women: A Randomized Study

The role of "mixed" orexigenic and anorexigenic signals and autoantibodies reacting with appetite-regulating neuropeptides and peptides of the adipose tissue-gut-brain axis: relevance to food intake and nutritional status in patients with anorexia nervosa and bulimia nervosa